spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 3. I{kappa}B{alpha}(Y42F) inhibits NF{kappa}B activation following pervanadate and H/R treatment. (A) HeLa cells were co-infected with Ad.I{kappa}B{alpha}(Y42F) or Ad.BglII together with Ad.NF{kappa}BLuc 24 hours before treatment. Cells were treated with UV (50 J/m2), TNF-{alpha}(10 ng/ml), pervanadate (50 µM) and H/R (5 hours hypoxia, 6 hours reoxygenation) then harvested 6 hours after treatment. Whole cell extracts were normalized by total protein content and subjected to luciferase assay. NF{kappa}B activity was determined by the relative luciferase activity (as light units). The relative NF{kappa}B activation was calculated by deducting the mean NF{kappa}B baseline activation for each vector group (in the absence of stimulation) from the corresponding individual values from the same vector group in the presence of stimulus. The relative NF{kappa}B activation is plotted for each individual stimulus (±s.e.m., n=6). (B) Percent NF{kappa}B inhibition by I{kappa}B{alpha}(Y42F) for each experimental point was calculated using the following formula: percent inhibition=1—(relative activation of each Ad.I{kappa}B{alpha}(Y42F) infected sample/mean relative activation of the Ad.BglII infected group). Results depict the mean (±s.e.m.) for n=6 independent data points in each group.





Right arrow Return to article